EP
ZYME icon

Essential Partners’s Zymeworks ZYME Stock Holding History

Essential Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314 Hold
12
– – ﹤0.01% 2559
2026
Q1 		$300 Hold
12
– – ﹤0.01% 2551
2025
Q4 		$316 Hold
12
– – ﹤0.01% 2329
2025
Q3 		$205 Sell
12
-2
-14% -$29 ﹤0.01% 2399
2025
Q2 		$176 Buy
+14
New +$167 ﹤0.01% 1976

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Essential Partners's ZYME Position: Q2 2026 in Review

Essential Partners held its Zymeworks (ZYME) position steady in Q2 2026 at 12 shares worth $314. The position accounts for ﹤0.01% of the portfolio, ranked #2559.

Essential Partners first reported a position in ZYME in Q2 2025 and has held it in 5 quarters since. The position peaked at $316 in Q4 2025. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Essential Partners held 12 shares of Zymeworks worth $314 as of Q2 2026.
  • Essential Partners left its Zymeworks share count unchanged in Q2 2026.
  • Zymeworks made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2559 holding.
  • Essential Partners first reported a position in Zymeworks in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Zymeworks position peaked at $316 in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.